why choose us

First received: May 25, 2023

Clinical Trial: Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)

Brief Summary: The purpose of this study is to learn if certain drug combinations are effective treatments for patients with advanced ER+/HER2- who have previously been treated with palbociclib, ribociclib, or abemaciclib.

Read more